z-logo
Premium
Periodic benefit‐risk evaluation reports have substantial promise to guide patient care and should be made publicly available
Author(s) -
Fralick Michael,
Kesselheim Aaron S.
Publication year - 2017
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.4177
Subject(s) - pharmacoeconomics , pharmacoepidemiology , medicine , family medicine , library science , pharmacology , intensive care medicine , medical prescription , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom